Case series of three malaria patients from Thailand infected with the simian parasite, Plasmodium cynomolgi.
Cynomolgi
Human
Macaques
Malaria
Plasmodium
Simian
Thailand
Journal
Malaria journal
ISSN: 1475-2875
Titre abrégé: Malar J
Pays: England
ID NLM: 101139802
Informations de publication
Date de publication:
06 May 2022
06 May 2022
Historique:
received:
05
01
2022
accepted:
20
04
2022
entrez:
6
5
2022
pubmed:
7
5
2022
medline:
11
5
2022
Statut:
epublish
Résumé
While human cases of Plasmodium knowlesi are now regularly recognized in Southeast Asia, infections with other simian malaria species, such as Plasmodium cynomolgi, are still rare. There has been a handful of clinical cases described, all from Malaysia, and retrospective studies of archived blood samples in Thailand and Cambodia have discovered the presence P. cynomolgi in isolates using polymerase chain reaction (PCR) assays. In Thailand, an ongoing malaria surveillance study enrolled two patients from Yala Province diagnosed with Plasmodium vivax by blood smear, but who were subsequently found to be negative by PCR. Expanded PCR testing of these isolates detected mono-infection with P. cynomolgi, the first time this has been reported in Thailand. Upon re-testing of 60 isolates collected from Yala, one other case was identified, a co-infection of P. cynomolgi and P. vivax. The clinical course for all three was relatively mild, with symptoms commonly seen in malaria: fever, chills and headaches. All infections were cured with a course of chloroquine and primaquine. In malaria-endemic areas with macaque populations, cases of simian malaria in humans are being reported at an increasing rate, although still comprise a very small percentage of total cases. Plasmodium cynomolgi and P. vivax are challenging to distinguish by blood smear; therefore, PCR can be employed when infections are suspected or as part of systematic malaria surveillance. As Thai MoPH policy schedules regular follow-up visits after each malaria infection, identifying those with P. cynomolgi will allow for monitoring of treatment efficacy, although at this time P. cynomolgi appears to have an uncomplicated clinical course and good response to commonly used anti-malarials.
Sections du résumé
BACKGROUND
BACKGROUND
While human cases of Plasmodium knowlesi are now regularly recognized in Southeast Asia, infections with other simian malaria species, such as Plasmodium cynomolgi, are still rare. There has been a handful of clinical cases described, all from Malaysia, and retrospective studies of archived blood samples in Thailand and Cambodia have discovered the presence P. cynomolgi in isolates using polymerase chain reaction (PCR) assays.
CASE PRESENTATION
METHODS
In Thailand, an ongoing malaria surveillance study enrolled two patients from Yala Province diagnosed with Plasmodium vivax by blood smear, but who were subsequently found to be negative by PCR. Expanded PCR testing of these isolates detected mono-infection with P. cynomolgi, the first time this has been reported in Thailand. Upon re-testing of 60 isolates collected from Yala, one other case was identified, a co-infection of P. cynomolgi and P. vivax. The clinical course for all three was relatively mild, with symptoms commonly seen in malaria: fever, chills and headaches. All infections were cured with a course of chloroquine and primaquine.
CONCLUSION
CONCLUSIONS
In malaria-endemic areas with macaque populations, cases of simian malaria in humans are being reported at an increasing rate, although still comprise a very small percentage of total cases. Plasmodium cynomolgi and P. vivax are challenging to distinguish by blood smear; therefore, PCR can be employed when infections are suspected or as part of systematic malaria surveillance. As Thai MoPH policy schedules regular follow-up visits after each malaria infection, identifying those with P. cynomolgi will allow for monitoring of treatment efficacy, although at this time P. cynomolgi appears to have an uncomplicated clinical course and good response to commonly used anti-malarials.
Identifiants
pubmed: 35524255
doi: 10.1186/s12936-022-04167-w
pii: 10.1186/s12936-022-04167-w
pmc: PMC9074209
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
142Subventions
Organisme : Armed Forces Health Surveillance Branch
ID : P0055_22_AF
Informations de copyright
© 2022. The Author(s).
Références
Emerg Infect Dis. 2021 Aug;27(8):2187-2191
pubmed: 34287122
PLoS One. 2013 Aug 29;8(8):e71539
pubmed: 24009663
Emerg Infect Dis. 2020 Aug;26(8):1801-1809
pubmed: 32687020
Malar J. 2011 Jul 29;10:212
pubmed: 21801400
Adv Parasitol. 2021;113:131-189
pubmed: 34620382
Emerg Infect Dis. 2019 Oct;25(10):1936-1939
pubmed: 31538931
J Infect Dis. 2019 Feb 15;219(5):695-702
pubmed: 30295822
Malar J. 2014 Feb 24;13:68
pubmed: 24564912
J Infect Dis. 2018 Jun 20;218(2):265-276
pubmed: 29554284
Am J Trop Med Hyg. 1982 Mar;31(2):211-25
pubmed: 7041663
Blood. 2017 Sep 14;130(11):1357-1363
pubmed: 28698207
J Clin Microbiol. 2013 Sep;51(9):2931-8
pubmed: 23804387
Emerg Infect Dis. 2021 Feb;27(2):590-593
pubmed: 33496236
Am J Trop Med Hyg. 1961 Sep;10:673-8
pubmed: 13694174
Am J Trop Med Hyg. 2019 Dec;101(6):1397-1401
pubmed: 31595871
Malar J. 2020 Oct 1;19(1):350
pubmed: 33004070
Malar J. 2016 Sep 02;15(1):450
pubmed: 27590474
Am J Trop Med Hyg. 2021 Nov 15;106(1):275-282
pubmed: 34781260
J Infect Dis. 2019 Nov 6;220(12):1946-1949
pubmed: 31418017